Fundz

Tnf Pharmaceuticals reported raising $7 Million in an initial SEC Form D filing, from an offering of $7 Million

PRIVATESep 05, 2025

Amount Raised

$7 Million

$7 Million sold, per SEC Form D (first sale Sep 2, 2025)

Round Type

Venture

New YorkBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Investors

New Strategic

Who to call at TNF Pharmaceuticals, and when

A new round usually means TNF Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day TNF Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at TNF Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at TNF Pharmaceuticals. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

TNF Pharmaceuticals

Location

New York, New York, United States

About

TNF Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing novel therapies for autoimmune and inflammatory conditions. The company aims to extend healthy lifespan by treating the underlying causes of diseases rather than just their symptoms. Its drug platforms include a small molecule, isomyosamine, which regulates the immune system, and Supera-CBD, aiming to treat chronic pain, addiction, and epilepsy. TNF is committed to addressing chronic inflammation and improving patient outcomes through its innovative therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment TNF Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for TNF Pharmaceuticals's next move

See what Strategic adds

TNF Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.